Physician profile

Shaf B Holden

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Huntsville, AL

NPI 1518161397

$32,382.85

in general payments reported to CMS, 2019-2025

38 companies · $1,291 in 2025

The $1,291 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,876.23
Travel and Lodging$2,436.60
Consulting Fee$1,995.00
Education$180.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $16,971.90 2019-2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Hemosphere
Atricure, INC. $5,384.39 2019-2025 Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax
Baxter Healthcare $4,085.03 2021-2025 Floseal, Preveleak, Coseal
Medtronic Vascular, INC. $1,448.34 2019-2020
Medtronic, INC. $1,253.70 2021-2025 Penditure, Mosaic, Corevalve Evolut R
Abiomed $937.62 2021-2025 Impella
Zimmer Biomet Holdings, INC. $508.49 2020-2024 Sternalock
Abbott Laboratories $299.36 2023-2024 Epic, Navitor
Lsi Solutions INC $228.95 2022-2023 Cor Knot
Artivion, INC. $207.81 2019-2025 Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive
Boston Scientific Corporation $158.01 2019-2020
Hemosonics LLC $150.52 2021-2022
Cook Medical LLC $58.86 2023-2024 Cook
Olympus America INC. $50.27 2019-2022
Surgical Specialties Corporation (US), INC. (Dba Corza Medical) $45.56 2025
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Elutia, INC. $44.52 2019-2023
Kls-Martin L.P. $38.98 2023
Janssen Pharmaceuticals, INC $37.75 2019
La Jolla Pharmaceutical Company $37.02 2025 Zevtera, Giapreza
E.R. Squibb & Sons, L.L.C. $34.92 2022-2023 Opdivo
Sanofi-Aventis U.S. LLC $34.81 2019
Angiodynamics, INC. $33.40 2025 Angiovac
Tela Bio, INC. $32.64 2022
Becton, Dickinson and Company $30.61 2025 Hemosphere
Convatec INC. $28.93 2024
Cook Biotech Incorporated $27.21 2023 Biodesign
Chiesi USA, INC. $26.22 2019-2021
Intuitive Surgical, INC. $24.44 2024
Astrazeneca Pharmaceuticals LP $23.53 2019-2020
Prime Surgical, LLC $20.97 2025
Livanova USA, INC. $19.98 2019
Amgen INC. $15.66 2019
Ethicon US, LLC $15.32 2024 Surgicel Nu-Knit, Evarrest
Lemaitre Vascular, INC. $15.08 2023 Tyke, Patch, Pledget and Intracardiac
Medela LLC $13.95 2022
Kci USA, INC. $13.01 2019
Sanara Medtech INC. $12.78 2022
Regeneron Healthcare Solutions, INC. $12.31 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Shaf B Holden

$32,382.85

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $1,291 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/67939/shaf-b-holden

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.